Rates of primary, secondary, and tertiary engraftment
. | Time to engraftment, day ± SD . | . | . | ||
|---|---|---|---|---|---|
| Xenograft . | Primary . | Secondary . | Tertiary . | ||
| ALL-2 | 53 ± 5 | 44 ± 6* | 32 ± 3* | ||
| ALL-3 | 25 ± 4 | 26 ± 3 | 30 ± 4 | ||
| ALL-4 | 57 ± 5 | 31 ± 3* | 30 ± 2* | ||
| ALL-7 | 19 ± 5 | 20 ± 2 | 19 ± 2 | ||
| ALL-8 | 47 ± 4 | 42 ± 5 | 41 ± 4 | ||
| ALL-10 | 31 ± 10 | 37 ± 11 | 31 ± 1 | ||
| ALL-11 | 45 ± 8 | 46 ± 3 | 45 ± 4 | ||
| ALL-16 | 55 ± 11 | 47 ± 3 | 39 ± 5* | ||
| ALL-17 | 64 ± 7 | 33 ± 4* | 38 ± 2* | ||
| ALL-19 | 29 ± 11 | 25 ± 6 | 27 ± 4 | ||
. | Time to engraftment, day ± SD . | . | . | ||
|---|---|---|---|---|---|
| Xenograft . | Primary . | Secondary . | Tertiary . | ||
| ALL-2 | 53 ± 5 | 44 ± 6* | 32 ± 3* | ||
| ALL-3 | 25 ± 4 | 26 ± 3 | 30 ± 4 | ||
| ALL-4 | 57 ± 5 | 31 ± 3* | 30 ± 2* | ||
| ALL-7 | 19 ± 5 | 20 ± 2 | 19 ± 2 | ||
| ALL-8 | 47 ± 4 | 42 ± 5 | 41 ± 4 | ||
| ALL-10 | 31 ± 10 | 37 ± 11 | 31 ± 1 | ||
| ALL-11 | 45 ± 8 | 46 ± 3 | 45 ± 4 | ||
| ALL-16 | 55 ± 11 | 47 ± 3 | 39 ± 5* | ||
| ALL-17 | 64 ± 7 | 33 ± 4* | 38 ± 2* | ||
| ALL-19 | 29 ± 11 | 25 ± 6 | 27 ± 4 | ||
Significantly different from rate of primary engraftment (P < .05).